# Germany Export Playbook for Europe

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks regional export playbook

Compare buyer markets, access conditions, and calculated product opportunities in Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.

## Navigation

- [Yugalinks home](https://www.yugalinks.com/)
- [Trade data](https://www.yugalinks.com/trade/)
- [Open country workspace](https://www.yugalinks.com/app/countries)
- [Data sources](https://www.yugalinks.com/data-sources)
- [Methodology](https://www.yugalinks.com/methodology)

## Overview

- Exporter: Germany (DEU)
- Region: Europe
- Latest trade year: 2024
- Buyer markets: 25
- Calculated three-year opportunity: $706.8B
- Reported FTA markets: 22
- Average reported distance: 1,009 km
- Average business entry indicator: 11 days

## Market comparison

| Market | ISO3 | Opportunity | Products | FTA | Distance | Entry days | Top product |
| --- | --- | ---: | ---: | --- | ---: | ---: | --- |
| United Kingdom | GBR | $116.0B | 26 | Reported | 495 km | 5 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| Netherlands | NLD | $92.0B | 23 | Reported | 174 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Belgium | BEL | $78.5B | 15 | Reported | 197 km | 5 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, Liechtenstein | CHE | $63.5B | 7 | Reported | 504 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| Italy | ITA | $60.6B | 12 | Reported | 1,146 km | 11 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| France | FRA | $53.7B | 17 | Reported | 440 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Slovenia | SVN | $42.0B | 6 | Reported | 815 km | 8 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof |
| Russia | RUS | $39.2B | 8 | Not reported | 2,065 km | 10 | Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc |
| Spain | ESP | $30.6B | 12 | Reported | 1,479 km | 13 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Poland | POL | $29.8B | 10 | Reported | 966 km | 37 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Ireland | IRL | $13.0B | 4 | Reported | 921 km | 11 | Electronic integrated circuits: processors and controllers, whether or not combined with memories, converters, logic circuits, amplifiers, clock and timing circuits, or other circuits |
| Hungary | HUN | $12.7B | 5 | Reported | 976 km | 7 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| Czechia | CZE | $11.6B | 4 | Reported | 546 km | 25 | Telephones for cellular networks or for other wireless networks |
| Greece | GRC | $9.9B | 3 | Reported | 1,991 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Denmark | DNK | $9.1B | 3 | Reported | 596 km | 4 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| Sweden | SWE | $7.9B | 2 | Reported | 1,119 km | 8 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Slovakia | SVK | $7.2B | 3 | Reported | 817 km | 22 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| Malta | MLT | $5.9B | 2 | Reported | 1,834 km | 21 | Vessels: n.e.s. in heading no. 8901, for the transport of goods and other vessels for the transport of both persons and goods |
| Finland | FIN | $4.7B | 1 | Reported | 1,475 km | 13 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Portugal | PRT | $4.4B | 2 | Reported | 1,892 km | 7 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Belarus | BLR | $3.8B | 2 | Not reported | 1,405 km | 9 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| Romania | ROU | $3.2B | 1 | Not reported | 0 km | 0 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Austria | AUT | $3.1B | 2 | Reported | 764 km | 21 | Telephones for cellular networks or for other wireless networks |
| Norway | NOR | $2.8B | 2 | Reported | 969 km | 4 | Product not reported |
| Ukraine | UKR | $1.5B | 1 | Reported | 1,646 km | 7 | Ammunition: n.e.s. in chapter 93 |

## Product and market opportunities

| Rank | Market | Product | Opportunity | Buyer growth | Current share |
| ---: | --- | --- | ---: | ---: | ---: |
| 1 | Belgium (BEL) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $20.7B | +7.6% | +0.0% |
| 2 | Switzerland, Liechtenstein (CHE) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $20.3B | +12.3% | +12.8% |
| 3 | United Kingdom (GBR) | HS 271121 - Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $19.3B | +16.1% | +0.3% |
| 4 | Netherlands (NLD) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.4B | +6.5% | +0.1% |
| 5 | Switzerland, Liechtenstein (CHE) | HS 710813 - Metals: gold, semi-manufactured | $17.0B | +14.3% | +0.5% |
| 6 | United Kingdom (GBR) | HS 710812 - Metals: gold, non-monetary, unwrought (but not powder) | $16.7B | +15.3% | +8.6% |
| 7 | United Kingdom (GBR) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $14.4B | +5.5% | +0.0% |
| 8 | Italy (ITA) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $13.0B | +5.3% | +0.0% |
| 9 | Belgium (BEL) | HS 271019 - Product description unavailable | $12.3B | +9.1% | +2.5% |
| 10 | Russia (RUS) | HS 870323 - Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc | $12.3B | +12.7% | +0.0% |
| 11 | Italy (ITA) | HS 293719 - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $11.3B | +29.0% | +2.5% |
| 12 | Slovenia (SVN) | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.3B | +34.8% | +0.0% |
| 13 | Italy (ITA) | HS 271121 - Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $10.8B | +7.2% | +0.3% |
| 14 | Slovenia (SVN) | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $10.5B | +30.0% | +0.0% |
| 15 | Netherlands (NLD) | HS 271019 - Product description unavailable | $10.0B | +12.2% | +5.3% |
| 16 | Switzerland, Liechtenstein (CHE) | HS 710812 - Metals: gold, non-monetary, unwrought (but not powder) | $9.9B | +12.8% | +5.8% |
| 17 | Poland (POL) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $9.9B | +8.1% | +0.0% |
| 18 | Slovenia (SVN) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.1B | +17.9% | +4.9% |
| 19 | Netherlands (NLD) | HS 271111 - Petroleum gases and other gaseous hydrocarbons: liquefied, natural gas | $8.5B | +22.5% | +0.0% |
| 20 | Russia (RUS) | HS 870322 - Vehicles: with only spark-ignition internal combustion piston engine, cylinder capacity over 1000 but not over 1500cc | $8.5B | +16.6% | +0.1% |

## Sector opportunities

| Sector | Products | Reported buyer imports | Opportunity | Average growth |
| --- | ---: | ---: | ---: | ---: |
| HS2 27 - HS2 sector 27 | 41 | $393.1B | $233.7B | +13.3% |
| HS2 30 - HS2 sector 30 | 18 | $157.1B | $75.4B | +16.5% |
| HS2 85 - HS2 sector 85 | 27 | $114.7B | $74.2B | +13.9% |
| HS2 71 - HS2 sector 71 | 10 | $216.7B | $62.8B | +11.8% |
| HS2 29 - HS2 sector 29 | 7 | $37.5B | $47.8B | +28.3% |
| HS2 00 - HS2 sector 00 | 11 | $144.2B | $47.3B | +8.6% |
| HS2 84 - HS2 sector 84 | 14 | $65.8B | $44.3B | +8.2% |
| HS2 87 - HS2 sector 87 | 12 | $54.9B | $42.3B | +22.8% |

## Frequently asked questions

### Should Germany focus on Europe?

Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.

### What does calculated opportunity mean?

It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.

### How should exporters use this page?

Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, tariffs, standards, logistics, pricing, and competition before acting.

Yugalinks presents derived views for research and planning. [Read the full methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.